Zoology · Biotechnology — Principles and Processes

Obtaining the Foreign Gene Product — Bioreactors

Section 9.3.5 of NCERT Class 12 Biology establishes that the ultimate goal of recombinant DNA technology is the production of a useful protein, and that achieving this at commercially relevant scale demands bioreactors. NEET tests this section both directly — asking which equipment is essential for industrial-scale microbial culture — and indirectly through downstream processing concepts. Expect one question per paper from this region of the chapter.

NCERT grounding

NCERT Class 12 Biology, Chapter 9, Section 9.3.5 opens the bioreactor discussion with a precise rationale: "Small volume cultures cannot yield appreciable quantities of products. To produce in large quantities, the development of bioreactors, where large volumes (100–1000 litres) of culture can be processed, was required." The text then defines a bioreactor as a vessel in which raw materials are biologically converted into specific products — including individual enzymes — using microbial, plant, animal or human cells, with provision for optimum growth conditions of temperature, pH, substrate, salts, vitamins and oxygen. NCERT describes and illustrates two variants: the simple stirred-tank and the sparged stirred-tank bioreactor (Figure 9.7 a and b). The section closes by specifying the six systems every stirred-tank must possess: agitator, oxygen delivery, foam control, temperature control, pH control and sampling ports.

"Bioreactors can be thought of as vessels in which raw materials are biologically converted into specific products, individual enzymes, etc., using microbial plant, animal or human cells."

NCERT Class 12 Biology, Chapter 9 — §9.3.5

Why bioreactors are needed

After a recombinant DNA construct is introduced into a host cell and the expression of the foreign gene has been verified at laboratory scale, the technology must be translated into commercial production. A recombinant protein is any protein whose gene is expressed in a heterologous (foreign) host; human insulin expressed in E. coli is the classic example. Laboratory-scale cultures in shake flasks typically hold 50–500 mL of medium. Even at maximum cell density the total protein yield is measured in micrograms — wholly inadequate for a therapeutic that must be dosed in milligram quantities to millions of patients.

The transition from bench to industrial scale is not merely a matter of using a larger flask. As culture volume increases, mass transfer of oxygen becomes the limiting factor: in a large, unstirred vessel, cells at the centre receive almost no dissolved oxygen and die, releasing proteases that degrade the target protein. Temperature gradients develop. pH drifts as CO2 accumulates. Foam generated by protein surfactants at the air-liquid interface can denature the product. Each of these problems is addressed by a purpose-designed bioreactor with dedicated engineering solutions for mixing, aeration, foam suppression, temperature control and pH regulation.

Bioprocess engineering — one of the two core pillars of modern biotechnology as defined by NCERT — encompasses the design of these vessels and the maintenance of sterile conditions to allow only the desired organism to grow. Without this engineering discipline, all of recombinant DNA technology would remain a laboratory curiosity.

100–1000 L

Bioreactor working volume (NCERT)

The NCERT figure of 100–1000 litres is the single most tested number from this section. Industrial insulin fermenters can exceed 10,000 litres, but NCERT specifies 100–1000 L as the defining range for a bioreactor.

Types of bioreactors

NCERT explicitly names two types, both of the stirred-tank category. These are the most widely used designs in pharmaceutical biotechnology because they provide excellent mixing and can be scaled from laboratory (2 L) to industrial (50,000 L) volumes with predictable engineering relationships.

Stirred-Tank Bioreactor Types — NCERT §9.3.5 (Figure 9.7)

Simple Stirred-Tank

Mechanical

Aeration method

  • Cylindrical vessel with curved base
  • Agitator (impeller) provides mixing and disperses dissolved O2 through shear
  • No direct sparging of air into culture
  • Oxygen transfer relies entirely on surface aeration and agitation
  • Suitable for organisms with lower oxygen demand
  • Simpler construction; lower capital cost
VS

Sparged Stirred-Tank

Pneumatic + Mechanical

Aeration method

  • Same cylindrical geometry with curved base
  • Agitator provides mixing
  • Sterile air is additionally sparged (bubbled) through a ring sparger at the vessel base
  • Far superior oxygen transfer efficiency
  • Essential for aerobic bacteria and yeast at high cell densities
  • Requires sterile air filtration upstream

Both designs share the same cylindrical shape with a curved (dished) base. The curved base is an engineering choice: flat-bottomed vessels create stagnant "dead zones" where cells settle and receive no nutrients or oxygen; the curved base forces convective currents to sweep the bottom continuously. The agitator shaft enters from the top (top-entry) or bottom (bottom-entry) and carries one or more impeller stages that break up gas bubbles and homogenise temperature and pH throughout the vessel.

Key components of the stirred-tank bioreactor

NCERT enumerates six distinct systems. Each has a defined function and NEET can probe any of them with a match-the-function question.

All six systems must be present for a vessel to qualify as a bioreactor in the NCERT sense. Omission of any one compromises product quality or sterility.

Agitator / Impeller System

Function: Even mixing throughout the vessel; dispersal of oxygen bubbles; prevention of cell settling.

Design: Multiple Rushton turbine impellers on a central shaft; rotation speed controlled by motor with variable frequency drive.

Key point: The impeller ensures uniform distribution of temperature, pH and dissolved oxygen — without it, concentration gradients would kill cells in stagnant zones.

Oxygen Delivery System

Function: Supplies dissolved oxygen to aerobic cells; inadequate O2 shifts cells to anaerobic fermentation with reduced yield.

Design: Sparger ring (in sparged tank) through which sterile, filtered air or pure O2 is pumped; or surface aeration only (simple tank).

Key point: Oxygen is poorly soluble in water (~8 mg/L at 37 °C). Continuous supply is mandatory for aerobic recombinant hosts like E. coli.

Foam Control System

Function: Suppresses foam generated by proteins and other surfactants at the gas-liquid interface.

Design: Antifoam agents (silicone oils, pluronic polymers) added automatically by a foam sensor; or mechanical foam breaker on shaft.

Key point: Uncontrolled foam can overflow the vessel, block exhaust filters, and — critically — cause protein denaturation at the air-liquid interface, reducing product yield.

Temperature Control System

Function: Maintains culture at the optimal temperature for host growth and target protein folding.

Design: External water/steam jacket or internal cooling/heating coils; temperature probe feeds a PID controller.

Key point: E. coli typically runs at 37 °C for biomass, then may be shifted to a lower temperature (e.g., 25 °C) to improve solubility of expressed protein.

pH Control System

Function: Maintains pH within the narrow range optimal for cell growth and protease stability.

Design: Sterilisable pH electrode; automatic addition of acid (H2SO4) or base (NaOH) via peristaltic pump.

Key point: As cells grow they excrete organic acids (acetate, lactate) that drop pH; unchecked acidification causes cell lysis and protein degradation.

Sampling Ports

Function: Allow periodic withdrawal of small volumes of culture for analysis (cell count, dissolved O2, metabolite levels, product titer) without opening the vessel.

Design: Aseptic sample valves with steam-sterilisable connections.

Key point: Sampling must not introduce contaminants — the port design is part of the sterility system, not an afterthought.

Culture modes: batch, fed-batch and continuous

How nutrients and cells are managed during a production run determines yield, productivity and cost. NCERT mentions continuous culture explicitly (Section 9.3.5: "cells can also be multiplied in a continuous culture system wherein the used medium is drained out from one side while fresh medium is added from the other to maintain the cells in their physiologically most active log/exponential phase"). The other two modes are standard bioprocess engineering knowledge required for full NEET preparation.

Culture Mode Comparison

NCERT §9.3.5 + standard bioprocess
  1. Mode 1

    Batch Culture

    All nutrients added at start. Cells grow through lag, log, stationary and decline phases. Vessel emptied, cleaned and re-inoculated for each run.

    Simple operation; low risk of contamination
  2. Mode 2

    Fed-Batch Culture

    Nutrients (especially carbon source) added incrementally during the run to extend the log phase and prevent substrate inhibition. Vessel not continuously drained.

    Higher yield; controls metabolite accumulation
  3. Mode 3

    Continuous Culture

    Spent medium removed at the same rate as fresh medium is added. Cells maintained at steady-state in the exponential phase. NCERT-named method for maximum biomass.

    Maximum productivity; complex sterility demands

In continuous culture (also called a chemostat), the dilution rate — the ratio of medium flow rate to vessel volume — determines cell density and growth rate. Operating at a dilution rate just below the maximum growth rate (washout point) gives the highest biomass and, therefore, the highest product titre per unit time. This is the mode NCERT references when it states that continuous culture "produces a larger biomass leading to higher yields of desired protein."

Figure 1 — Bioreactor schematic Sparged Stirred-Tank Bioreactor — Annotated Diagram Jacket / Coils Motor Impeller Sparger ring Sterile air in Exhaust gas Sample port pH / T probe Foam sensor Sparged Stirred-Tank Bioreactor NCERT Fig. 9.7(b) schematic

Figure 1. Cross-sectional schematic of a sparged stirred-tank bioreactor. The motor drives two impeller stages on a central shaft for uniform mixing. Sterile air enters via the sparger ring at the base; bubbles rise and are broken by the impellers to maximise oxygen transfer. The foam sensor triggers antifoam addition at the surface; pH and temperature probes feed controllers; the sampling port allows aseptic culture withdrawal.

Recombinant products — commercial examples

The rationale for large-scale bioreactor culture is the manufacture of therapeutic proteins that cannot be obtained in adequate quantities from natural sources. NIOS Table 30.3 provides the most comprehensive list; NCERT focuses on the concept without exhaustive enumeration. NEET may ask which protein is produced by recombinant technology for a specific disease.

Recombinant Product Host System Therapeutic Use Milestone
Human Insulin (Humulin) E. coli Diabetes mellitus First approved recombinant protein (1982)
Human Growth Hormone (hGH) E. coli / mammalian cells Pituitary dwarfism Replaced cadaver-derived hGH (eliminates CJD risk)
Erythropoietin (EPO) CHO cells Anaemia (chronic renal failure) Requires glycosylation — mammalian host essential
Interferons (IFN-α, IFN-β, IFN-γ) E. coli Viral infections; certain cancers Previously obtainable only in nanogram quantities from blood
Interleukin-2 (IL-2) E. coli Cancer immunotherapy
Factor VIII CHO cells Haemophilia A Eliminates blood-transfusion-derived HIV risk
Factor IX CHO cells Haemophilia B
Hepatitis B surface antigen (HBsAg) Saccharomyces cerevisiae Hepatitis B vaccine antigen Second-generation vaccine (recombinant)
Tissue Plasminogen Activator (tPA) CHO cells Dissolves blood clots — heart attack/stroke

The production of human insulin in 1982 stands as the landmark event because it demonstrated that a human gene could be expressed in a bacterium, the recombinant protein could be produced at tonne scale in bioreactors, and it could be purified to a standard safe for injection. The process used two separate E. coli fermentations — one for the A-chain, one for the B-chain — with subsequent chemical joining; modern processes express the entire proinsulin sequence and rely on proteolytic processing. Either way, the bioreactor is the production engine.

Sterile conditions — the non-negotiable constraint

The most fundamental requirement distinguishing a bioreactor from an ordinary mixing vessel is sterility. Recombinant microorganisms are typically non-competitive in the environment; any contaminating bacterium introduced during the run would outgrow the production strain within hours and destroy the batch. Bioprocess engineering — the second pillar of modern biotechnology as stated in NCERT 9.1 — is largely concerned with this problem.

Sterile conditions are achieved through a hierarchy of measures. The vessel and all associated pipework, valves and sensors are sterilised in place (SIP) by flowing steam at 121 °C and 15 psi for 15–30 minutes — the same autoclave principle applied to the entire production system. All gases entering the vessel (air for the sparger, nitrogen for tank pressurisation) pass through validated HEPA-grade or membrane filters rated at 0.22 µm, which retain bacteria and bacteriophage. Additions of medium supplements, antifoam agents, acid and base are made through closed, steam-sterilised lines. The sampling port design includes steam barriers that prevent backflow of environmental air into the vessel when a sample is withdrawn.

Figure 2 — Culture growth phases & fed-batch feeding Batch vs Fed-Batch Culture: Cell Density Over Time Time → Cell density → Feed pulses Lag Log Stat. Decline Batch culture Fed-batch (nutrient feed extends log phase)

Figure 2. Comparison of batch (solid teal) and fed-batch (dashed green) culture kinetics. In batch culture cells traverse lag, log, stationary and decline phases as nutrients deplete. In fed-batch, periodic substrate additions (arrows) maintain cells in log phase, preventing substrate limitation and extending the period of maximum productivity. The area under the fed-batch curve represents a substantially larger total biomass and protein yield.

The management of oxygen transfer is the dominant engineering challenge at scale. The volumetric oxygen transfer coefficient (kLa) must be maintained above the oxygen uptake rate of the cells. In a sparged stirred-tank, kLa is a function of agitation speed, aeration rate and impeller design. When oxygen becomes limiting, aerobic bacteria switch to anaerobic pathways, producing acetate or ethanol instead of the target protein — a critical loss of product fidelity.

Worked examples

Worked example 1

A bioreactor used for recombinant protein production must possess which set of systems according to NCERT?

Answer: According to NCERT §9.3.5, a stirred-tank bioreactor must have: (i) an agitator system, (ii) an oxygen delivery system, (iii) a foam control system, (iv) a temperature control system, (v) a pH control system, and (vi) sampling ports. Any question listing these six must match them to "stirred-tank bioreactor." The curved base facilitating mixing of reactor contents is also mentioned in NCERT and may appear as a distractor — it is a structural feature, not a system.

Worked example 2

Distinguish the function of a sparger from that of an impeller in a sparged stirred-tank bioreactor.

Answer: The sparger introduces sterile air as fine bubbles at the base of the vessel, providing the oxygen source for aerobic cells. The impeller (agitator) mixes the culture, breaking large air bubbles into smaller ones (increasing gas-liquid contact area), distributing dissolved oxygen uniformly throughout the vessel, and preventing cell sedimentation. Without the impeller, oxygen would be consumed near the sparger and cells in the rest of the vessel would starve; without the sparger (in the simple stirred-tank design), all oxygen must transfer from the headspace, limiting productivity at high cell densities.

Worked example 3

Why is the continuous culture mode said to produce "larger biomass leading to higher yields of desired protein" compared with simple batch culture?

Answer: In batch culture, nutrients are finite and cells inevitably enter stationary and decline phases — during which growth stops and proteases may degrade the product. In continuous culture, fresh medium enters and spent medium exits at equal rates, keeping nutrient concentrations constant and cells permanently in the exponential (log) phase — the phase of maximum growth rate and metabolic activity. Because the exponential phase is sustained indefinitely rather than being a transient window, total biomass produced per unit time is far greater, and the cells are always in their most productive physiological state. NCERT explicitly identifies this as the reason for employing continuous culture (§9.3.5).

Worked example 4

Human insulin produced by recombinant technology was the first commercial success of this approach (1982). What host organism was used and why was it chosen?

Answer: The first recombinant human insulin (Humulin) was produced in Escherichia coli. The rationale: (i) E. coli grows rapidly to high cell densities on cheap carbon sources; (ii) its genetics were well characterised and strong promoters were available to drive high-level expression; (iii) it lacks the endogenous insulin-like signals that would complicate selection; (iv) its fermentation in bioreactors at scale was industrially mature. The insulin A and B chains were expressed separately, then combined chemically (Genentech's original process); modern processes express proinsulin and use proteolytic processing to generate mature insulin.

Common confusion & NEET traps

Simple Stirred-Tank vs Sparged Stirred-Tank — NEET Distinction

Simple Stirred-Tank

  • Agitator only for O2 distribution
  • Surface aeration from headspace
  • Lower oxygen transfer rate
  • Suitable for lower cell-density cultures
  • NCERT Figure 9.7(a)
VS

Sparged Stirred-Tank

  • Agitator + sparger for O2 distribution
  • Sterile air bubbled through sparger
  • Higher oxygen transfer rate
  • Preferred for aerobic high-density culture
  • NCERT Figure 9.7(b)

NEET PYQ Snapshot — Bioreactors & Foreign Gene Product

Questions from 2016–2025 directly testing bioreactor knowledge and related production concepts.

NEET 2019

Which one of the following equipments is essentially required for growing microbes on a large scale, for industrial production of enzymes?

  1. BOD incubator
  2. Sludge digester
  3. Industrial oven
  4. Bioreactor
Answer: (4)

Why: Bioreactors process 100–1000 litres of culture under optimal temperature, pH, O2, substrate and vitamin conditions — the only option that addresses large-scale industrial microbial culture. BOD incubators measure biological oxygen demand in water samples; sludge digesters are used in sewage treatment; industrial ovens are used for heat processing.

NEET 2017

The process of separation and purification of expressed protein before marketing is called:

  1. Postproduction processing
  2. Upstream processing
  3. Downstream processing
  4. Bioprocessing
Answer: (3)

Why: NCERT §9.3.6 defines the series of processes (separation and purification) after the biosynthetic stage collectively as "downstream processing." The term derives from industrial flow diagrams where the bioreactor is upstream. This question tests the boundary between what happens inside the bioreactor (biosynthesis) and what follows (downstream processing).

Concept

In a stirred-tank bioreactor, the function of the foam control system is to:

  1. Regulate pH of the culture medium
  2. Prevent protein denaturation at the gas-liquid interface and vessel overflow
  3. Deliver sterile air through the culture
  4. Withdraw periodic culture samples for analysis
Answer: (2)

Why: Foam forms when proteins act as surfactants at the air-liquid interface. If uncontrolled, foam overflows through the exhaust and the target protein is denatured at the interface — two distinct losses. Options (3) and (4) describe the oxygen delivery and sampling port functions respectively; option (1) describes the pH control system.

Concept

In which type of culture system is used medium continuously drained out while fresh medium is simultaneously added to maintain cells in the exponential growth phase?

  1. Batch culture
  2. Fed-batch culture
  3. Continuous culture
  4. Shake-flask culture
Answer: (3)

Why: NCERT §9.3.5 states explicitly: "cells can also be multiplied in a continuous culture system wherein the used medium is drained out from one side while fresh medium is added from the other to maintain the cells in their physiologically most active log/exponential phase." Batch culture adds all nutrients at once; fed-batch adds nutrients incrementally but does not drain spent medium continuously; shake-flask culture is laboratory-scale, not industrial.

FAQs — Bioreactors & Foreign Gene Product

Frequently asked questions on bioreactor design, culture modes and recombinant protein production.

What is a bioreactor and why is it used in biotechnology?

A bioreactor is a large vessel (100–1000 litres) in which raw materials are biologically converted into specific products using microbial, plant, animal or human cells. It is used because small laboratory cultures cannot yield commercially useful quantities of recombinant protein. The bioreactor provides optimal conditions of temperature, pH, oxygen, substrate, salts and vitamins to maximise product yield.

What is the difference between a simple stirred-tank bioreactor and a sparged stirred-tank bioreactor?

In a simple stirred-tank bioreactor the agitator mixes the culture and distributes dissolved oxygen through mechanical action alone. In a sparged stirred-tank bioreactor, sterile air is additionally bubbled (sparged) directly through the culture via a sparger ring at the base, greatly increasing oxygen transfer efficiency. Both are cylindrical with a curved base; the sparged design is preferred for aerobic organisms requiring high oxygen demand.

What are the key components of a stirred-tank bioreactor?

A stirred-tank bioreactor contains: (1) an agitator/impeller system for mixing; (2) an oxygen delivery system (mechanical or sparger); (3) a foam control system to prevent protein denaturation at the air-liquid interface; (4) a temperature control system (jacket or coils); (5) a pH control system with probes and acid/base feed; and (6) sampling ports for periodic withdrawal of small culture volumes for analysis.

What is the difference between batch, fed-batch and continuous culture in bioreactors?

In batch culture all nutrients are added at the start; cells grow, produce product and then decline as nutrients deplete. In fed-batch culture fresh medium or substrate is added incrementally during the run to extend the productive growth phase and increase yield. In continuous culture, used medium is drained from one side while fresh medium is added from the other, maintaining cells at a constant physiologically active (exponential) phase for maximum biomass and product output.

Which NEET PYQ directly tests knowledge of bioreactors?

NEET 2019 Q.23 asked: 'Which one of the following equipments is essentially required for growing microbes on a large scale for industrial production of enzymes?' The correct answer was (4) Bioreactor. This tests the core NCERT statement that large-scale production of recombinant proteins requires bioreactors capable of processing 100–1000 litres of culture.

What recombinant proteins are produced in bioreactors?

Major recombinant proteins produced in bioreactors include: human insulin (first approved in 1982, for diabetes mellitus), human growth hormone (hGH, for pituitary dwarfism), erythropoietin (for anaemia), interferons (for viral infections and cancer), interleukin-2 (for cancer), clotting factors VIII and IX (for haemophilia A and B), and recombinant vaccine antigens (e.g., hepatitis B surface antigen).

What happens after biosynthesis in the bioreactor?

After biosynthesis, the product undergoes downstream processing — a series of separation and purification steps before marketing. These include cell disruption or secretion harvesting, centrifugation or filtration, chromatographic purification, and formulation with suitable preservatives. Each product requires its own downstream protocol, and all must undergo rigorous quality control and clinical trials before approval.